Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 18, 2006The Journal of Infectious Diseases

Immunotherapy for Drug‐Refractory Mucosal Leishmaniasis

View Full Paper
Ask AI
Bookmark
Share

Authors

RBRoberto BadaróILIza LoboAMAlvaro Munõs

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Badaró et al. (2006) studied this question.

synapsesocial.com/papers/6a6d066f35aa2c282cdfc299https://doi.org/10.1086/507708
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1rK39 Enzyme-Linked Immunosorbent Assay for Diagnosis of Leishmania donovani Infection1998 · 130 citations
  2. 2A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.1995 · 156 citations
  3. 3Stimulation by Granulocyte-Macrophage Colony-Stimulating Factor of <i>Leishmania Tropica</i> Killing by Macrophages1979 · 227 citations
  4. 4Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Reverses Neutropenia and Reduces Secondary Infections in Visceral Leishmaniasis1994 · 57 citations
  5. 5Protection against Cutaneous Leishmaniasis Induced by Recombinant Antigens in Murine and Nonhuman Primate Models of the Human Disease2001 · 159 citations